# US 2006/0068500 A1 · Detecting yeast infections using a lateral flow assay

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2006/0068500 A1
- Document ID: US20060068500A1
- Status: Published application
- Kind: A1
- Application number: 10/951,367
- Filed: 2004-09-28
- Published: 2006-03-30
- Earliest claimed: 2004-09-28
- Assignees: Kimberly-Clark Worldwide, Inc.
- Inventors: Ning Wei; Shu-Ping Yang; Rosann Kaylor
- Web page: https://patentgrep.com/patent/US20060068500A1

## CPC

- G01N 33/54388: {based on lateral flow}
- G01N 2333/40: from Candida
- G01N: INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES (measuring or testing apparatus or processes other than immunoassay, involving enzymes or microorganisms C12M, C12Q)

## Abstract

There is provided a lateral flow assay device for detecting the presence or quantity of an analyte residing in a test sample where the lateral flow assay device has a porous membrane in liquid communication with a conjugate pad and a wicking pad. The conjugate pad has a gold colloid-containing detection probe. The porous membrane has a detection zone where an immobilized first capture reagent configured to bind to at least a portion of the analyte and analyte-conjugate complexes to generate a detection signal. The control zone is located downstream from the detection zone on the porous membrane and has a second capture reagent immobilized within the control zone. The conjugate pad is located upstream from the detection zone, and has detection probes with specific binding members for the analyte. A sample containing an analyte is deposited on the conjugate pad, interacts with the detection probes, and moves toward the control zone for detection.

## Claims

### Claim 1

A lateral flow assay device for detecting the presence or quantity of an analyte residing in a test sample, said lateral flow assay device comprising a porous membrane in liquid communication with a conjugate pad and a wicking pad:
said conjugate pad located upstream from a detection zone, said conjugate pad having detection probes with specific binding members for the analyte comprising nanoparticies and;
said detection zone having an immobilized first capture reagent, said first capture reagent being configured to bind to at least a portion of said analyte and analyte-conjugate complexes to generate a detection signal having an intensity;
a control zone located downstream from said detection zone, wherein a second capture reagent is immobilized within said control zone, said second capture reagent being configured to bind to said conjugate or conjugate-analyte complexes;
wherein a sample containing said analyte is deposited on said conjugate pad and said sample moves toward said control zone.

### Claim 2 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said conjugated detection probes comprise a substance selected from the group consisting of chromogens, catalysts, luminescent compounds, radioactive compounds, visual labels, liposomes, and combinations thereof.

### Claim 3 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said conjugated detection probes comprise a luminescent compound.

### Claim 4 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said conjugated detection probes comprise a visual label.

### Claim 5 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said specific binding member is selected from the group consisting of antigens, haptens, aptamers, primary or secondary antibodies, biotin, and combinations thereof.

### Claim 6 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said first capture reagent is selected from the group consisting of antigens, haptens, protein A or G, neutravidin, avidin, streptavidin, captavidin, primary or secondary antibodies, and complexes thereof.

### Claim 7 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said second capture reagent is selected from the group consisting of antigens, haptens, protein A or G, neutravidin, avidin, streptavidin, captavidin, primary or secondary antibodies, and complexes thereof.

### Claim 8 (depends on 1)

A lateral flow assay device as defined in claim 1, wherein said analyte is Candida albicans.

### Claim 9

A method for detecting the presence or quantity of an analyte residing in a test sample, said method comprising:
i) providing a lateral flow assay device comprising a porous membrane, in liquid communication with a conjugate pad and a wicking pad, said conjugate pad having nanoparticle detection probes conjugated with a specific binding member for the analyte, said porous membrane defining a detection zone in which a first capture reagent is immobilized and a control zone within which a second capture reagent is immobilized, wherein said control zone is located downstream from said detection zone;
ii) contacting said test sample containing the analyte with the conjugate pad;
iii) detecting a detection signal.

### Claim 10 (depends on 9)

A method as defined in claim 9, wherein said conjugated detection probes comprise a substance selected from the group consisting of chromogens, catalysts, luminescent compounds, radioactive compounds, visual labels, liposomes, and combinations thereof.

### Claim 11 (depends on 9)

A method as defined in claim 9, wherein said conjugated detection probes comprise a visual label.

### Claim 12 (depends on 9)

A method as defined in claim 9, wherein said specific binding member is selected from the group consisting of antigens, haptens, aptamers, primary or secondary antibodies, biotin, and combinations thereof.

### Claim 13 (depends on 9)

A method as defined in claim 9, wherein said first capture reagent is selected from the group consisting of antigens, haptens, protein A or G, neutravidin, avidin, streptavidin, captavidin, primary or secondary antibodies, and complexes thereof.

### Claim 14 (depends on 9)

A method as defined in claim 9, wherein said second capture reagent is selected from the group consisting of antigens, haptens, protein A or G, neutravidin, avidin, streptavidin, captavidin, primary or secondary antibodies, and complexes thereof.

### Claim 15 (depends on 9)

A method as defined in claim 9, wherein said second capture reagent comprises a polyelectrolyte.

### Claim 16 (depends on 9)

A method as defined in claim 9, wherein said analyte is Candida albicans.
